论文信息 - Neoadjuvant capecitabine and oxaliplatin (XELOX) combined with bevacizumab for high-risk localized rectal cancer - 字舞流文

Neoadjuvant capecitabine and oxaliplatin (XELOX) combined with bevacizumab for high-risk localized rectal cancer

Y. Doki | M. Mori | I. Takemasa | T. Mizushima | M. Ikeda | S. Noura | Y. Miyake | Hirofumi Yamamoto | J. Nishimura | H. Takemoto | Ho Min Kim | M. Fujii | J. Hasegawa | R. Nezu | Takeshi Kato | H. Miwa | Y. Fujie | H. Tamagawa | M. Sekimoto | H. Kim